NOVONIX director reports holding 309,508 shares

NOVONIX Ltd director Jean Oelwang filed an initial Form 3 disclosing current holdings in the company.

Accepted by SEC EDGAR 03/16/2026 - 06:54 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NOVONIX Ltd director Jean Oelwang filed an initial Form 3 disclosing current holdings in the company. The filing reports direct ownership of 309,508 ordinary shares of NOVONIX as of the reported date, with no associated purchase, sale, or derivative transactions described.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Oelwang Jean

Role Director

Type	Security	Shares	Price	Value
Holding	Ordinary shares	--	--	--

Holdings: Ordinary shares — 309,508 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jean Oelwang's Form 3 filing for NOVONIX (NVX) show?

The Form 3 shows that director Jean Oelwang directly holds 309,508 ordinary shares of NOVONIX Ltd. This is an initial ownership report, not a record of a new stock purchase or sale transaction.

Is Jean Oelwang buying or selling NOVONIX (NVX) shares in this Form 3?

This Form 3 does not report any share purchases or sales. It simply states Jean Oelwang’s existing direct ownership of 309,508 ordinary shares, serving as an initial statement of beneficial ownership as a company director.

How many NOVONIX (NVX) shares does director Jean Oelwang own?

Director Jean Oelwang is reported to directly own 309,508 ordinary shares of NOVONIX Ltd. This figure reflects the position shown in the Form 3 filing and does not include any derivative securities in this report.

Does the NOVONIX (NVX) Form 3 include any options or derivative securities?

No derivative securities are listed in this Form 3. The filing only reports direct ownership of 309,508 ordinary shares of NOVONIX Ltd, and the derivative holdings section is shown as empty in this report.

What is the significance of a Form 3 filing for NOVONIX (NVX) insiders?

A Form 3 is an insider’s initial statement of beneficial ownership. For NOVONIX, this filing records director Jean Oelwang’s direct holding of 309,508 ordinary shares, establishing a baseline for any future Form 4 or Form 5 transaction reports.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Oelwang Jean

(Last) (First) (Middle)

1029 WEST 19TH STREET

(Street)

CHATTANOOGA TN 37408

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
NOVONIX Ltd [ NVX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	309,508	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Suzanne Yeates	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.